ID1 and glioblastoma: While further research is required to detail the interactions between ID-1 regulation, AMPK signaling, and metabolic reprogramming in glioblastoma cells, our data suggests that reprogramming of 1-C mediated purine synthesis plays a role in glioblastoma cell proliferation and treatment resistance.